Key result
Catheter-based ablation suppresses symptomatic atrial fibrillation in approximately 70% of patients, offering an effective alternative for those refractory or intolerant to antiarrhythmic drugs.
Catheter-based AF ablation is discussed as an interventional option for rhythm control that may offer mortality reduction benefits without medication complications.
May support ablation for drug-refractory AF; leaves open mortality benefit confirmation in prospective trials.
Atrial fibrillation (AF) contributes to considerable morbidity, with increasing risk of stroke, complications from anticoagulation, and exacerbation of heart failure. AF ablation has become a commonly performed procedure in many hospitals as the procedural techniques evolve rapidly with improved success. Here we discuss the interventional options of catheter-based AF ablation for rhythm control, which offers the benefit of mortality reduction associated with normal sinus rhythm but without medication complications.
No takes yet. Share an insight, caveat, or question.
Voroshilovsky et al. (2010) conducted a review in Atrial Fibrillation. Catheter-based ablation vs. Antiarrhythmic drugs was evaluated. Catheter-based ablation suppresses symptomatic atrial fibrillation in approximately 70% of patients, offering an effective alternative for those refractory or intolerant to antiarrhythmic drugs.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: